| mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0005 |
| mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0005 |
| mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0006 |
| mRNA |
BRD-K09344309 |
CTRPv2 |
pan-cancer |
AAC |
0.26 |
0.0006 |
| mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0007 |
| mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0007 |
| mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0009 |
| mRNA |
BRD-K20514654 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
0.001 |
| mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.001 |
| mRNA |
SRT-1720 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.001 |